Index.php

Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. Pharmaceutical companies, such as the makers of Xarelto, have a duty to ensure that their drugs are reasonably safe for use - and failure to accomplish so may possibly be grounds for compensation. Our lawyers are operating hard to obtain these hurt by the drug the compensation they're entitled to.

Even though bleeding is a typical complication connected with anticoagulants, it has been alleged that Xarelto is much more unsafe than classic blood thinners because no antidote exists to reverse its blood-thinning side effects of xarelto 20 mg. This indicates that, inside the event of an emergency, sufferers may possibly be at threat for irreversible bleeding difficulties, including life-threatening internal and gastrointestinal hemorrhaging.

In the event you or perhaps a loved one particular suffered a serious bleeding occasion right after taking Xarelto, you might have legal recourse. For more info, make contact with us nowadays to possess your case reviewed, free of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are in search of compensation from Bayer and Janssen for previous and future health-related bills, lost wages, pain and suffering and, in instances of death, funeral expenses. Furthermore, they are searching for punitive damages, that are usually awarded to punish the defendant and deter other businesses from acting similarly.
Why Are Lawsuits Being Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike classic anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Since of this, the lawsuits claim, doctors have no effective implies of stopping Xarelto users from bleeding within the event of an emergency. Plaintiffs within the lawsuits allege severe and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a secure anticoagulant option.
Doctors and health-related staff were not properly made aware of methods to stabilize and treat a Xarelto user in the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing hazardous clotting.

Visit this page for far more data on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

The attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.